APOLIPOPROTEIN A1 MODIFICATIONS RELATED TO COGNITIVE DECLINE IN TYPE 2 DIABETES AND PRECLINICAL ALZHEIMER'S DISEASE
$712,508FY2022Defense Health AgencyDOD
The Cleveland Clinic Foundation
Investigators
View source on USAspending →APOLIPOPROTEIN A1 MODIFICATIONS RELATED TO COGNITIVE DECLINE IN TYPE 2 DIABETES AND PRECLINICAL ALZHEIMER'S DISEASE · GrantIndex